Jean-Philippe Michel

Jean-Philippe Michel

Auto-generated profile, based on publicly available information

Jean-Philippe Michel

Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400, Orsay, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
IZIslam Zmerli
Islam Zmerli
JMJean-Philippe Michel
Jean-Philippe Michel
AMAli Makky
Ali Makky
We established tightly controlled experimental conditions to synthesize polydopamine nanoparticles with well-defined and reproducible physicochemical properties such as size, yield and nanomechanics.

14 April 2021 in Multifunctional Materials
Verified
Journal Article
Closed access
PDF file
IZIslam Zmerli
Islam Zmerli
JMJean-Philippe Michel
Jean-Philippe Michel
AMAli Makky
Ali Makky
Polydopamine (PDA) is a mussel-inspired and a melanin-mimicking material that has attracted considerable attention during the recent years. This ‘polymer’ displays diverse promising properties, like its simple preparation procedures, easy functionalization, free radicals scavenging activity, outstanding photothermal and photoacoustic performance, and its great biocompatibility and biodegradability. A remarkable feature of PDA is its ability to form colloidal nanosized particles or nanoscaled coatings, allowing the preparation of various nanoparticulate structures. The first studies into PDA mainly explored the polymerization mechanisms of this material and the development of controlled preparation protocols. Later works focused on the investigation of these nanomaterials for the design and development of multifunctional platforms and their implementation in multiple biomedical fields, particularly in cancer treatment and bio-imaging. The purpose of this review is to (a) give a detailed overview about the synthesis methods of PDA and the formation mechanisms proposed so far in the literature, (b) outline the remarkable physico-chemical and functional properties of PDA nanomaterials, and (c) summarize the application of PDA-derived nanosystems in cancer theranostics and particularly in drug delivery and light-mediated cancer therapy with a special emphasis on the different strategies that can be used for the design of smart nanosystems with bimodal photothermal/photodynamic properties. Finally, a comparison of physicochemical properties and biomedical applications between PDA and other catecholamine derivatives is made.

1 November 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ECEleonore Coppens
Eleonore Coppens
DDDidier Desmaële
Didier Desmaële
TNTimothée Naret
Timothée Naret
SGSébastien Garcia-Argote
Sébastien Garcia-Argote
SFSophie Feuillastre
Sophie Feuillastre
SMSimona Mura
Simona Mura

19 February 2020 in Langmuir
Verified
Journal Article
Closed access
MGMaroua Gabaji
Maroua Gabaji
JMJérôme Médard
Jérôme Médard
AHArnaud Hemmerle
Arnaud Hemmerle
JPJean Pinson
Jean Pinson
JMJean-Philippe Michel
Jean-Philippe Michel

1 November 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RDRaul Diaz-Salmeron
Raul Diaz-Salmeron
ACAntonio Da Costa
Antonio Da Costa
JMJean-Philippe Michel
Jean-Philippe Michel
GPGilles Ponchel
Gilles Ponchel
KBKawthar Bouchemal
Kawthar Bouchemal

22 October 2021 in Langmuir
Verified
Journal Article
Closed access
JMJérôme Médard
Jérôme Médard
XSXiaonan SUN
Xiaonan SUN
JPJean Pinson
Jean Pinson
DLDa Li
Da Li
Claire MangeneyClaire Mangeney
Claire Mangeney
JMJean-Philippe Michel
Jean-Philippe Michel